During the past decade, Hospital de Morón conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Morón" #1 collaborator was "Latin American Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Morón" are "Breast Cancer" (2 trials), "Epidemiology" (1 trials) and "Respiration, Artificial" (1 trials). Many other conditions were trialed in "Hospital de Morón" in a lesser frequency.

Most popular intervention types in "Hospital de Morón" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ado-trastuzumab emtamsine" (1 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials) and "Pertuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Morón" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital de Morón". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital de Morón, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Morón, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".